Showing 4761-4770 of 20470 results for "".
- 177Lu-PSMA-617 Outcomes in Octogenarians With mCRPChttps://reachmd.com/news/177lu-psma-617-outcomes-in-octogenarians-with-mcrpc/2486911/Key Takeaways More than half of patients had a PSA50 response, and progression-free and overall survival were reported in the same treated cohort. Hospitalization during therapy was common, and serious hematologic toxicities included anemia and thrombo
- New AMD Severity Scores Separate Dry and Wet Diseasehttps://reachmd.com/news/new-amd-severity-scores-separate-dry-and-wet-disease/2486905/Key Takeaways Separate AMD-D and AMD-W scores were derived from AREDS and AREDS2 features, rescaled to 0 to 10, and were moderately correlated in Eye ACT. AMD-D increased with age among untreated eyes, while AMD-W generally increased before initial ant
- Aesthetic Record Acquires JOYA Health to Expand Employer-Linked Skin Care Accesshttps://reachmd.com/news/aesthetic-record-acquires-joya-health-to-expand-employer-linked-skin-care-access/2486904/Aesthetic Record, a widely used electronic medical record (EMR) and practice management platform in aesthetics, has announced its acquisition of JOYA Health, a company focused on employer-sponsored skin health benefits. The transaction underscores a broader trend toward specialized, consumer-driv
- UCSD Receives Grant for Gene-Edited Stem Cell Therapy in FRDAhttps://reachmd.com/news/ucsd-gene-edited-stem-cell-therapy-frda/2486915/Key Takeaways A $7.4 million award supports advancement of a first-of-its-kind stem cell-based gene therapy program for Friedreich's ataxia. The approach uses autologous blood-forming stem cells edited with CRISPR-Cas9 and is intended to restore fratax
- Photobiomodulation Shows Vision Gains in Dry AMD at 24 Monthshttps://reachmd.com/news/photobiomodulation-vision-gains-dry-amd/2486895/Key Takeaways In LIGHTSITE III, most treated eyes gained at least 5 letters by month 21, and smaller proportions achieved gains of 10 or 15 letters. No phototoxicity was reported, ocular adverse-event rates were similar between groups, and progression
- TEE-Guided CPR in Out-Of-Hospital Cardiac Arresthttps://reachmd.com/news/tee-guided-cpr-out-of-hospital-cardiac-arrest/2486896/Key Takeaways Sustained ROSC was similar across groups despite image-guided compression-site adjustment. Higher intra-CPR end-tidal carbon dioxide was observed during minutes 11 to 20 after emergency department arrival in the TEE-guided group.
- Dermalogica Enters Device Market With FDA-Cleared Microneedling Systemhttps://reachmd.com/news/dermalogica-enters-device-market-with-fda-cleared-microneedling-system/2486887/Dermalogica has announced the launch of its PRO Pen Microneedling System following US Food and Drug Administration (FDA) 510(k) clearance, marking the company’s first entry into the medical device category. The device is indicated for the treatment of facial acne scars in adults aged 22 years and
- Dr. Miriam Bettencourt Speaks on Measles Resurgence and the Dermatologist’s Rolehttps://reachmd.com/news/dr-miriam-bettencourt-speaks-on-measles-resurgence-and-the-dermatologists-role/2486877/As the ominous music from the “Mission Impossible” movies played over the speakers, a dramatic voice spoke: “Good morning, doctors. Sixty years of safe and effective vaccine has resulted in the eradication of measles. Recently, however, a distrust of science has pr
- DWI Abnormalities and Stroke in Patients Treated With Lecanemabhttps://reachmd.com/news/dwi-abnormalities-and-stroke-in-patients-treated-with-lecanemab/2486855/Key Takeaways Interval stroke, defined as diffusion-weighted imaging abnormalities consistent with stroke, was reported in 11 of 261 lecanemab-treated patients during follow-up. The lesions were small, asymptomatic, and were most often cerebellar or co
- CYP2D6-Guided Opioid Prescribing Falls Short After Surgeryhttps://reachmd.com/news/cyp2d6-guided-opioid-prescribing-falls-short-after-surgery/2486859/Key Takeaways The 10-day Silverman integrated analgesic assessment was not different between guided care and usual care. Phenotype-concordant prescribing was more common with genotype guidance, with less hydrocodone prescribing and more hydromorphone p